Auszug
Unter thrombotischen Mikroangiopathien (TMA) versteht man einerseits das hämolytisch-urämische Syndrom (HUS; synonym M. Gasser) und andererseits die thrombotisch-thrombozytopenische Purpura (TTP; synonym M. Moschkowitz), die ähnliche pathologische und pathoanatomische Besonderheiten aufweisen. Die TMA ist eine Krankheit der kleineren Gefäße, der Arteriolen und Kapillaren, die mit einer lokalen Thrombosierung und einer Thrombopenie einhergeht.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
European Society for Pediatric Nephrology (ESPN) (2006) ▪
Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R (1955) Hämolytisch-urämische Syndrome: Bilaterale Nierenrindennekrosen bei akuten erworbenen Anämien. Schweiz Med Wochenschr 85: 905–909
Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB (2002) Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study. J Infect Dis 186: 493–500
Gerber A, Kirchhoff-Moradpour AH, Obieglo S et al. (2003) Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality. Pediatr Nephrol 18: 952–955
Ho VT, Cutler C, Carter S et al. (2005) Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11: 571–575
Karch H (1996) Control of enterohemorrhagic Escherichia coli infection-the need for a network involving microbiological laboratories and clinical and public health institutions. Eur J Clin Microbiol Infect Dis 15: 276–280
Meilmann A, Bielaszewska M, Zimmerhackl LB, Prager R, Harmsen D, Tschape H, Karch H (2005) Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin Infect Dis 41: 785–792
O’Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM (2004) British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 126: 11–28
Siegler R, Oakes R (2005) Hemolytic uremic syndrome; pathogenesis, treatment, and outcome. Curr Opin Pediatr 17: 200–204
Repetto HA (1997) Epidemic hemolytic-uremic syndrome in children. Kidney Int 52:1708–1719
Verweyen HM, Karch H, Brandis B, Zimmerhackl LB (2000) Infections due to enterohemorrhagic E. coli: how to follow the routes of transmission. Pediatr Nephrol 14: 73–83
Zimmerhackl LB, Besbas N, Van de Kar N et al. (2006) Epidemiology clinic and pathophysiology of atypical/recurrent haemolytic uraemic syndrome. Seminars in Thrombosis and Hemostasis, in press
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Zimmerhackl, L.B. (2007). Thrombotische Mikroangiopathien. In: Lentze, M.J., Schulte, F.J., Schaub, J., Spranger, J. (eds) Pädiatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76460-1_182
Download citation
DOI: https://doi.org/10.1007/978-3-540-76460-1_182
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71895-6
Online ISBN: 978-3-540-76460-1
eBook Packages: Medicine (German Language)